Exploring bacterial enzymes that incorporate halogens into organic molecules
Identification, characterization, and application of bacterial site-specific vanadium-dependent haloperoxidase enzymes
This study is exploring special enzymes from bacteria that can help add halogen atoms to organic compounds in a safe and eco-friendly way, which could lead to better methods for making important natural products without harmful waste.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Cruz NIH-funded |
| Lab location | 1 site (Santa Cruz, United States) |
| Project ID | NIH-11083113 on NIH RePORTER |
What this research studies
This research investigates a unique family of bacterial enzymes known as vanadium-dependent haloperoxidases (VHPOs) that can efficiently incorporate halogen atoms into organic compounds. By utilizing natural processes, these enzymes aim to perform halogenation reactions with minimal waste and without toxic byproducts. The project employs a combination of chemical, biochemical, and genomic techniques to characterize these enzymes and understand their potential applications in creating bioactive natural products. This could lead to safer and more sustainable methods for synthesizing important chemical compounds.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in the development of new biotechnological applications and sustainable chemical processes.
Not a fit: Patients who are not involved in biochemistry or do not have an interest in the applications of enzymatic processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more environmentally friendly approach to synthesizing valuable organic molecules used in pharmaceuticals and other industries.
How similar studies have performed: While the specific enzymes being studied are less characterized, similar enzymatic approaches have shown promise in other research, indicating potential for success.
Where this research is happening
Santa Cruz, United States
- University of California Santa Cruz — Santa Cruz, United States (Active)
Researchers
- Principal investigator: Mckinnie, Shaun Mitchell Kirk — University of California Santa Cruz
- Study coordinator: Mckinnie, Shaun Mitchell Kirk
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.